Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced the results of ...

DNA forms loops to bring the enhancer (orange) and promoter (green) regions closer together so that the activator can affect ...

The tools needed to pinpoint the problematic variants have been lacking. To fill this gap, Farh and his team have developed a deep neural network— PromoterAI —that accurately identifies promoter ...

This study demonstrates that Setd2 overexpression rescues bivalent gene expression during zygotic genome activation (ZGA) in ...

Enhanced Genomics has formed a partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge to ...

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...

A breakthrough assay is advancing how researchers observe gene expression in real time. Named QRIVTA (quantitative real-time ...

In Say Hello to the Bad Guys: How Professional Wrestling’s New World Order Changed America, the ESPN reporter Marc Raimondi ...

Scientists just sequenced the first sea spider genome, uncovering genetic clues to limb growth, regeneration, and ancient ...

Driving this vision is Mathew Job, whose professional journey in corporate India includes key leadership roles and a focus on strategic growth and innovation.